These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16434890)

  • 21. The prognostic impact of extracapsular lymph node involvement in rectal cancer patients: Implications for staging and adjuvant treatment strategies.
    Brabender J; Bollschweiler E; Hölscher AH; Strobel K; Gutschow C; Prenzel K; Grimminger P; Drebber U; Schröder W; Metzger R; Vallböhmer D
    Oncol Lett; 2012 Apr; 3(4):825-830. PubMed ID: 22741001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2010 Jan; 34(1):1-9. PubMed ID: 19898226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
    Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular markers predicting lymph node metastasis in early esophageal cancer.
    Plum PS; Warnecke-Eberz U; Dhaouadi O; Alakus H; Drebber U; Metzger R; Prenzel KL; Hölscher AH; Bollschweiler E
    Histol Histopathol; 2015 Oct; 30(10):1193-202. PubMed ID: 25869644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ratio of invaded to removed lymph nodes as a prognostic factor in adenocarcinoma of the distal esophagus and esophagogastric junction.
    Saha S; Dehn TC
    Dis Esophagus; 2001; 14(1):32-6. PubMed ID: 11422303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracapsular lymph node involvement is a robust survival predictor in esophageal cancer patients: A pooled analysis.
    Chen D; Mao Y; Zheng Y; Wen J; Song P; Xue Y; Wang W; Sang Y; Chen Y; Dai C
    Eur J Surg Oncol; 2021 Aug; 47(8):1875-1882. PubMed ID: 33795171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pT2 Adenocarcinoma of the esophagus: early or advanced cancer?
    Metzger R; Lorenz D; Gockel I; Origer J; Plum PS; Junginger T; Drebber U; Hansen T; Krümpelmann K; Fisseler-Eckhoff A; Lang H; Hölscher AH; Bollschweiler E
    Ann Thorac Surg; 2013 Nov; 96(5):1840-5. PubMed ID: 23987902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
    Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
    Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification.
    Lerut T; Moons J; Coosemans W; Van Raemdonck D; De Leyn P; Decaluwé H; Decker G; Nafteux P
    Ann Surg; 2009 Nov; 250(5):798-807. PubMed ID: 19809297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
    Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction.
    van de Ven C; De Leyn P; Coosemans W; Van Raemdonck D; Lerut T
    Eur J Cardiothorac Surg; 1999 Jun; 15(6):769-73. PubMed ID: 10431857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum tumor-associated glycoprotein 72, a helpful predictor of lymph nodes invasion in esophagogastric junction adenocarcinoma.
    Xu Y; Chen Y; Wei L; Lai S; Zheng W; Wu F
    Biochem Biophys Res Commun; 2019 Jan; 509(1):133-137. PubMed ID: 30579602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic significance of the number of dissected lymph nodes in Siewert type Ⅱadenocarcinoma of the esophagogastric junction without lymphatic metastasis].
    Wang JQ; Wei DZ; Xie MR; Xu SB; Ma DC
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):300-4. PubMed ID: 27087378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of extracapsular lymph node involvement on the prognosis of patients with esophageal squamous cell carcinoma.
    Wang M; Yue M; Zhao X; He X; Zhang H; Jin J; Wang H
    Technol Health Care; 2023; 31(5):1771-1786. PubMed ID: 37125578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
    Lagarde SM; Phillips AW; Navidi M; Disep B; Griffin SM
    Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.